Literature DB >> 15166446

Molecular determinants of antigenicity of two subtypes of the tick-borne flavivirus Omsk haemorrhagic fever virus.

Li Li1, Pierre E Rollin2, Stuart T Nichol2, Robert E Shope1, Alan D T Barrett1, Michael R Holbrook1.   

Abstract

In 1964, D. H. Clarke defined two antigenic subtypes of Omsk haemorrhagic fever virus (OHFV) based on polyclonal antibody absorption and haemagglutination assays. The current report defines the molecular basis for these antigenic subtypes by comparison of the complete genomes of OHFV strains Kubrin (subtype I) and Bogoluvovska (subtype II). There were six nucleotide differences between these two strains throughout the entire genome and they encoded four amino acid changes including three in the viral envelope (E) protein. Two of these changes were in solvent-exposed regions of domain 3 of the E protein, one of which lies in a region that could easily function in virus-host cell or virus-antibody interactions. These results demonstrate the minimal changes that are required to significantly alter the antigenicity of flaviviruses and also demonstrate the tremendous genetic stability of the tick-borne flaviviruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166446     DOI: 10.1099/vir.0.19766-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

Review 1.  The fauna and perspective of rodentia ectoparasites in Iran relying on their roles within public health and veterinary characteristics.

Authors:  Mousa Khosravani
Journal:  J Parasit Dis       Date:  2017-10-03

2.  First Indications of Omsk Haemorrhagic Fever Virus beyond Russia.

Authors:  Edith Wagner; Anna Shin; Nur Tukhanova; Nurkeldi Turebekov; Talgat Nurmakhanov; Vitaliy Sutyagin; Almas Berdibekov; Nurbek Maikanov; Ilmars Lezdinsh; Zhanna Shapiyeva; Alexander Shevtsov; Klaus Freimüller; Lukas Peintner; Christina Ehrhardt; Sandra Essbauer
Journal:  Viruses       Date:  2022-04-04       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.